Abstract
Vasculitis is a broad, characterized by inflammation of the blood vessel that leads to various clinical manifestations depending on which organ systems are involved. Evaluation of patient should include a thorough history, physical examination, laboratory tests, and histopathology studies. When it’s possible, therapeutic approach is to find out and to remove the causative agent.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Reference
Hautmann G, Campanile G, Lotti TM. The many faces of cutaneous vasculitis. Clin Dermatol. 1999;17(5):515–31.
Further Reading
Buggiani G, Krysenka A, Grazzini M, Vasku V, Hercogova J, Lotti T. Paraneoplastic vasculitis and paraneoplastic vascular syndromes. Dermatol Ther. 2010;23(6):597–605.
Calvo Catala J, et al. Efficacy of adalimumab in Behçet’s disease. Description of 6 cases. Reumatol Clin. 2011;7(4):258–61.
Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol. 2006;24:414–29.
De Merton M, Mahr A. Treating polyarteritis nodosa: current state of art. Clin Exp Rheumatol. 2011;29(1 suppl 64):110–6.
Di Lernia V. Mycoplasma pneumonia: an aetiological agent of acute haemorrhagic edema of infancy. Australas J Dermatol. 2013.
Haeberle MT, Adams WB, Callen JP. Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil. Arch Dermatol. 2012;148(8):887–8.
Kawakami T. A review of pediatric vasculitis with a focus on juvenile polyarteritis nodosa. Am J Clin Dermatol. 2012;13(6):389–98.
Kawakami T, Soma Y. Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa. J Am Acad Dermatol. 2010;63(4):602–6.
Krishnan S, Bhaumi DS, Kartik S. Rituximab in refractory cutaneous polyarteritis. Int J Rheum Dis. 2012;15(5):127.
Lotti TM, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Relation to systemic disease. Adv Exp Med Biol. 1999;455:115–25.
Mukhtyar C, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310–7.
Oliveira AC, Buosi AL, Dutra LA, de Suoza AW. Behçet disease: clinical features and management in a Brazilian tertiary hospital. J Clin Rheumatol. 2011;17(8):416–20.
Rolle AS, Zimmermann B, Poon SH. Etanercept-induced Henoch-Schönlein purpura in a patient with ankylosing spondylitis. J Clin Rheumatol. 2013;19(2):90–3.
Seneschal J, et al. Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone sensitive erythema elevatum diutinum. Dermatology. 2012;224(2):115–9.
Takahashi H, Fukami Y, Honma M, Ishida yamamoto A, Lizuka H. Successful combination therapy with dapsone and cyclosporine for erythema elevatum diutinum with unusual appearance. J Dermatol. 2012;39(5):486–7.
Tsampau D, Buggiani G, Hercogova J, Lotti T. Cutaneous necrotizing vasculitis: a rational therapeutic approach. Dermatol Ther. 2012;25(4):335–9.
Wollina U, Schönlebe J. Segmental leukocytoclastic vasculitis in herpes zoster. Int J Dermatol. 2012;51(11):1351–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gianfaldoni, S., D’Erme, A.M., Hercogová, J., Lotti, T.M. (2015). Cutaneous Vasculitis. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_17
Download citation
DOI: https://doi.org/10.1007/978-3-662-45139-7_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45138-0
Online ISBN: 978-3-662-45139-7
eBook Packages: MedicineMedicine (R0)